V1 sact_drug_detail
6,385,827 rows · 11 columns
| MERGED_DRUG_DETAIL_ID | MERGED_CYCLE_ID | ORG_CODE_OF_DRUG_PROVIDER | ACTUAL_DOSE_PER_ADMINISTRATION | OPCS_DELIVERY_CODE | ADMINISTRATION_ROUTE | ADMINISTRATION_DATE | DRUG_GROUP | MERGED_PATIENT_ID | MERGED_TUMOUR_ID | MERGED_REGIMEN_ID |
|---|---|---|---|---|---|---|---|---|---|---|
| 16628406 | 330007318 | EEI00 | 34 | X721 | 1 | 2017-12-14 | NOT CHEMO | 330008953 | 330004120 | 330007320 |
| 16628407 | 330007318 | EE813 | 2880 | X721 | 1 | 2017-12-14 | ETOPOSIDE | 330008953 | 330004120 | 330007320 |
| 16628408 | 330007318 | EJR | 3000 | X724 | 1 | 2017-12-14 | IFOSFAMIDE | 330008953 | 330004120 | 330007320 |
| 16628409 | 330007318 | EJU04 | 150 | X721 | 1 | 2017-12-15 | DOCETAXEL | 330008953 | 330004120 | 330007320 |
| 16628410 | 330007318 | EN201 | 300 | X721 | 1 | 2017-12-15 | NOT CHEMO | 330008953 | 330004120 | 330007320 |
| 16628411 | 330007318 | EOI | 1 | X721 | 1 | 2017-12-16 | NOT CHEMO | 330008953 | 330004120 | 330007320 |
| 16628412 | 330007319 | ECL01 | 100 | x724 | 1 | 2016-04-22 | NOT CHEMO | 330008964 | 330012400 | 330007321 |
| 16628413 | 330007319 | EK1EN | 20 | null | 1 | 2016-04-22 | ETOPOSIDE | 330008964 | 330012400 | 330007321 |
| 16628414 | 330007319 | EGU02 | 3000 | X724 | null | 2016-04-22 | IFOSFAMIDE | 330008964 | 330012400 | 330007321 |
| 16628415 | 330007319 | E0N03 | 150 | X724 | 1 | 2016-04-22 | ETOPOSIDE | 330008964 | 330012400 | 330007321 |
| 16628416 | 330007319 | ECL02 | 160 | X721 | 1 | 2016-04-23 | DOXORUBICIN | 330008964 | 330012400 | 330007321 |
| 16628417 | 330007319 | EE813 | 1450 | null | 1 | 2016-04-24 | FLUOROURACIL | 330008964 | 330012400 | 330007321 |
| 16628418 | 330007319 | ERA20 | 1200 | X721 | 1 | 2016-04-25 | FLUOROURACIL | 330008964 | 330012400 | 330007321 |
| 16628419 | 330007320 | E1UZ0 | 2 | X724 | 2 | 2015-07-04 | IPILIMUMAB | 330008964 | 330012400 | 330007322 |
| 16628420 | 330007320 | EK1EN | 0 | X724 | 1 | 2015-07-04 | TOPOTECAN | 330008964 | 330012400 | 330007322 |
| 16628421 | 330007320 | EE813 | 0 | X721 | 1 | 2015-07-04 | DOXORUBICIN | 330008964 | 330012400 | 330007322 |
| 16628422 | 330007321 | ECL02 | 74 | null | 1 | 2017-07-24 | NOT CHEMO | 330008977 | 330004121 | 330007323 |
| 16628423 | 330007321 | ETG | 0 | null | 5 | 2017-07-24 | CARBOPLATIN | 330008977 | 330004121 | 330007323 |
| 16628424 | 330007322 | EK1EN | 150 | null | null | null | NOT CHEMO | 330008977 | 330004125 | 330007324 |
| 16628425 | 330007322 | EE813 | 0 | X721 | 1 | null | TRIAL | 330008977 | 330004125 | 330007324 |
| 16628426 | 330007322 | EE813 | 4640 | X729 | 1 | null | IFOSFAMIDE | 330008977 | 330004125 | 330007324 |
| 16628427 | 330007322 | EEI00 | 18 | X724 | 2 | null | ETOPOSIDE | 330008977 | 330004125 | 330007324 |
| 16628428 | 330007322 | EEI00 | 35 | X721 | 2 | null | DACTINOMYCIN | 330008977 | 330004125 | 330007324 |
| 16628429 | 330007322 | EE813 | 0 | X724 | 11 | null | NOT CHEMO | 330008977 | 330004125 | 330007324 |
| 16628430 | 330007322 | EOI | 0 | null | 1 | null | NOT CHEMO | 330008977 | 330004125 | 330007324 |
| 16628431 | 330007322 | EJS03 | 8 | X722 | 1 | null | NOT CHEMO | 330008977 | 330004125 | 330007324 |
| 16628432 | 330007323 | EKA | 55 | null | 1 | 2014-01-15 | NOT CHEMO | 330008992 | 330004126 | 330007325 |
| 16628433 | 330007323 | ERS12 | 5500 | null | 2 | 2014-01-15 | AVELUMAB | 330008992 | 330004126 | 330007325 |
| 16628434 | 330007324 | ERA20 | 55 | X728 | 2 | 2014-02-10 | CETUXIMAB | 330009018 | 330004127 | 330007326 |
| 16628435 | 330007324 | EOI | 2640 | X724 | 1 | 2014-02-10 | IFOSFAMIDE | 330009018 | 330004127 | 330007326 |
| 16628436 | 330007325 | EKA | 55 | X729 | 1 | 2015-09-30 | CARBOPLATIN | 330009018 | 330004128 | 330007327 |
| 16628437 | 330007325 | EEI00 | null | X724 | 1 | 2015-09-30 | TOPOTECAN | 330009018 | 330004128 | 330007327 |
| 16628438 | 330007325 | EGU08 | 230 | null | null | 2015-10-01 | ETOPOSIDE | 330009018 | 330004128 | 330007327 |
| 16628439 | 330007325 | EOF | 310 | null | 1 | 2015-10-02 | ETOPOSIDE | 330009018 | 330004128 | 330007327 |
| 16628440 | 330007325 | EEI00 | 0.75 | null | 1 | 2015-10-02 | ETOPOSIDE | 330009018 | 330004128 | 330007327 |
| 16628441 | 330007325 | EOI | 8 | X724 | 1 | 2015-10-02 | STEROID | 330009018 | 330004128 | 330007327 |
| 16628442 | 330007325 | EOI | 8 | X724 | 2 | 2015-10-02 | STEROID | 330009018 | 330004128 | 330007327 |
| 16628443 | 330007325 | EN901 | 5500 | X722 | 1 | 2015-10-02 | FLUOROURACIL | 330009018 | 330004128 | 330007327 |
| 16628444 | 330007326 | ECL02 | 5360 | X729 | 1 | 2015-10-09 | ETOPOSIDE | 330009018 | 330004128 | 330007328 |
| 16628445 | 330007326 | EEI00 | 3200 | X721 | 1 | 2015-10-16 | TRIAL | 330009018 | 330004128 | 330007328 |
| 16628446 | 330007326 | EEI00 | 22 | X721 | 1 | 2015-10-16 | ETOPOSIDE | 330009018 | 330004128 | 330007328 |
| 16628447 | 330007326 | EEI00 | 20 | null | 1 | 2015-10-19 | IFOSFAMIDE | 330009018 | 330004128 | 330007328 |
| 16628448 | 330007326 | EEI00 | 41 | X721 | 1 | 2015-10-19 | IFOSFAMIDE | 330009018 | 330004128 | 330007328 |
| 16628449 | 330007326 | EN201 | 130 | null | 1 | 2015-10-20 | DOCETAXEL | 330009018 | 330004128 | 330007328 |
| 16628450 | 330007327 | EGU08 | 814.5 | X724 | 1 | 2014-11-11 | BEVACIZUMAB | 330009018 | 330004128 | 330007329 |
| 16628451 | 330007327 | EEI00 | 210 | X724 | 1 | 2014-11-12 | CETUXIMAB | 330009018 | 330004128 | 330007329 |
| 16628452 | 330007328 | ED301 | 814.5 | null | 1 | 2017-09-11 | BEVACIZUMAB | 330009032 | 330012403 | 330007330 |
| 16628453 | 330007328 | EE813 | 125 | X721 | 2 | 2017-09-18 | STEROID | 330009032 | 330012403 | 330007330 |
| 16628454 | 330007331 | EJR | 2040 | X729 | 1 | 2014-06-27 | BEVACIZUMAB | 330009044 | 330004134 | 330007333 |
| 16628455 | 330007331 | Haqrsvarq | 2960 | X724 | 1 | 2014-07-04 | FLUOROURACIL | 330009044 | 330004134 | 330007333 |